Amy Musiek - Concepedia

Author

Amy Musiek

Washington University in St. Louis ORCID

Also Known As

A. Musiek, A.C. Musiek, Amy C M Musiek, Amy C Musiek, Amy C. M. Musiek, Amy C. Musiek, Amy C.M. Musiek, Amy Musiek, N Raval

110

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Washington University in St. Louis University of Pennsylvania Massachusetts General Hospital Harvard University University of Alabama at Birmingham

About

Amy Musiek is an author at Washington University in St. Louis specializing in medicine, dermatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.1K
2	Allergy	2	2	32
3	Public Health	1	1	10
4	Cell Biology	1	1	20
5	Epidemiology	1	1	10

Amy Musiek

Publications

Citations

H-Index

Page 1

	Year	Citations
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial Youn H. Kim, M. Bagot, Lauren Pinter‐Brown, The Lancet Oncology Cutaneous T-cell LymphomaLymphoid NeoplasiaMedicinePathologyMogamulizumab Versus Vorinostat	2018	621
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation Rizwan Romee, Sarah Cooley, Melissa M. Berrien-Elliott, Blood	2018	397
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States Robert G. Micheletti, Zelma C. Chiesa Fuxench, Megan H. Noe, Journal of Investigative Dermatology Adult PatientsSurgical PathologyPathologyMulticenter Retrospective StudyDermatology	2018	134
Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis—ABCD-10 Megan H. Noe, Misha Rosenbach, Rebecca A. Hubbard, JAMA Dermatology	2019	105
Chronic Inflammation Promotes Skin Carcinogenesis in Cancer-Prone Discoid Lupus Erythematosus Anniek Zaalberg, Sara Moradi Tuchayi, Amir H. Ameri, Journal of Investigative Dermatology InflammationAutoimmune DiseaseLupusCutaneous BiologyImmunology	2018	49
Mogamulizumab-Associated Cutaneous Granulomatous Drug Eruption Mimicking Mycosis Fungoides but Possibly Indicating Durable Clinical Response Lu Chen, Kenneth R. Carson, Karl Staser, JAMA Dermatology Case Series ReportSurgical PathologyPathologyClinical DermatologyDermatology	2019	46
Expression of helper T cell master regulators in inflammatory dermatoses and primary cutaneous T-cell lymphomas: Diagnostic implications Andy C. Hsi, Sena J. Lee, Ilana S. Rosman, Journal of the American Academy of Dermatology Lymphoid NeoplasiaAutoimmune DiseaseMedicineT-regulatory CellImmune Regulation	2014	45
Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides) Ellen J. Kim, Aaron R. Mangold, Jennifer DeSimone, JAMA Dermatology	2022	43
The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma Ellen J. Kim, Joan Guitart, Christiane Querfeld, American Journal of Clinical Dermatology	2021	38
Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial Richard Cowan, Julia Scarisbrick, Pier Luigi Zinzani, Journal of the European Academy of Dermatology and Venereology	2021	37

Page 1